Skip to main content Skip to main navigation menu Skip to site footer

Hematologic Recovery in Pediatric Patients with Acute Lymphoblastic Leukemia After Induction Chemotherapy

  • Sony Wicaksono ,
  • Mia Ratwita Andarsini ,
  • I Dewa Gede Ugrasena ,
  • Andi Cahyadi ,
  • Maria Christina Shanty Larasati ,
  • Susanto Nugroho ,

Abstract

Link of Video Abstract: https://youtu.be/ulLjSscae2Q

 

Introduction: Myelosuppression in Acute Lymphoblastic Leukemia (ALL) children was associated with high morbidity and mortality. Chemotherapy was aimed to achieve remission conditions, including the elimination of blast cells in the bone marrow. However, the evidence of hematologic recovery after induction chemotherapy was poorly described. This study aimed to evaluate the profile of peripheral blood and the outcome of children with ALL after induction chemotherapy.

Methods: A prospective study was conducted in the Hematology-Oncology Pediatric Department at Saiful Anwar Hospital Malang. Patients <15 years old who were newly diagnosed as ALL were enrolled in this study. Peripheral blood examinations were performed on the 1st, 2nd, 4th, and 6th weeks. Clinical outcomes were evaluated by remission status. Comparison and correlation analysis were done by IBM SPSS for Windows, version 26. P-value <0,05 was considered significant. 

Result: There were 27 children included in this study. The median age was 5 years. There were 15 males and 17 females, 18 patients with LLA-L2 and 9 patients with LLA-L1. All patients received chemotherapy regimens according to the 2018 National Protocol for ALL. The median hemoglobin level was significantly increased after induction chemotherapy (p< 0.05). Meanwhile, the reticulocyte count increased in the 2nd week after induction chemotherapy. The Absolute Neutrophil Count (ANC) significantly improved and reached the normal limit in 4th week after chemotherapy induction. The platelet count and Immature Platelet Fraction (IPF) also increased significantly (p< 0.05) and reached the normal limit in 4th week after induction of chemotherapy.

Conclusion: Three cell lines regenerate at different rates at induction chemotherapy, with rapid erythrocyte recovery and slow neutrophil and platelet recovery.

References

  1. Chan KW. Acute lymphoblastic leukemia. Curr Probl Pediatr Adolesc Health Care. 2002;32(2):40-9. Available from https://doi.org/10.1067/mps.2002.121790
  2. Supriyadi E, Widjajanto P H, Purwanto I, Cloos J, Veerman AJP, Sutaryo S. Incidence of childhood leukemia in Yogyakarta, Indonesia, 1998 - 2009. Pediatr Blood Cancer. 2011;57:588-93. Available from 10.1002/pbc.23109
  3. Lund B, Åsberg A, Heyman M, Kanerva J, Harila-Saari A, Hasle H, et al. Risk factors for treatment related mortality in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;56(4):551–559. Available from https://doi.org/10.1002/pbc.22719
  4. Nguyen TV, Melville A, Nath S, Story C, Howell S, Sutton R, Zannettino A, Revesz T. Bone marrow recovery by morphometry during induction chemotherapy for acute lymphoblastic leukemia in children. PloS one. 2015;10(5):e0126233. Available from https://doi.org/10.1371/journal.pone.0126233
  5. Grunnan JD, Rosthoj S. Time course of peripheral blood count recovery during induction chemotherapy for childhood acute lymphoblastic leukemia. Hematology. 2019 Jan 1;24(1):467-72. Available from https://doi.org/10.1080/16078454.2019.1621019
  6. Purwanto YM, Gunawan S, Nafianti S, Purnomosari D, Intansari US, Westra G, Sutaryo JC. Immunophenotypic patterns of childhood acute leukemias in Indonesia. Asian Pacific Journal of Cancer Prevention. 2011;12:3381-7. Available from https://journal.waocp.org/article_26070.html
  7. Faderl S, Estrov Z. Hematopoietic recovery following induction therapy of acute leukemias: prognostic implications and a new look at the definition of remission. Leuk. Lymphoma. 2004;45(1):67–71. Available from https://doi.org/10.1080/1042819031000151914
  8. Zeidler L, Zimmermann M, Möricke A, Meissner B, Bartels D, Tschan C, et al. Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome. Haematologica. 2012;97(3):402–409. Available from https://doi.org/10.3324/haematol.2011.045229
  9. Kusuma Angkasa Y, Suryawan N, and Prihatni D. Clinical and Laboratory Manifestation of Children with Acute Lymphoblastic Leukemia as an Assessment of Severity: A Study in Dr. Hasan Sadikin General Hospital. Althea Medical Journal. 2019;6(2): 65-70. Available from https://journal.fk.unpad.ac.id/index.php/amj/article/view/1528
  10. Teuffel O, Stanulla M, Cario G, Ludwig W, Rottgers S, Schafer B, Zimmermann M, Schrappe M, and Niggli F. Anemia and Survival in Childhood Acute Lymphoblastic Leukemia. Haematologica. 2008;93(11):1652-1657. Available from https://www.zora.uzh.ch/id/eprint/33790/
  11. Raja-Sabudin R, Othman A, Ahmed-Mohamed K, Ithnin A, Alauddin H, Alias A, Abdul-Latif Z, Das S, Abdul-Wahid F, and Hussin N. Immature Reticulocyte Fraction is an Early Predictor of Bone Marrow Recovery Post Chemotherapy in Patients with Acute Leukemia. Saudi Med J. 2014;35(4): 346-349. Available from https://pesquisa.bvsalud.org/portal/resource/pt/emr-159350
  12. Strauß G, Vollert C, von Stackelberg A, Weimann A, Gaedicke G, and Schulze H. Immature Platelet Count: a Simple Parameter for Distinguishing Thrombocytopenia in Pediatric Acute Lymphocytic Leukemia From Immune Thrombocytopenia. Pediatr Blood Cancer. 2011;57(4):641-647. Available from https://doi.org/10.1002/pbc.22907
  13. Agrawal, V., Kayal, S., Ganesan, P., Dubashi, B. Chemotherapy Delays Are Associated with Inferior Outcome in Acute Lymphoblastic Leukemia: A Retrospective Study from a Tertiary Cancer Center in South India. Indian J Med Paediatr Oncol. 2021;42(01):51-60. Available from https://doi.org/10.1055/s-0041-1729513
  14. Puła, A., Zdunek, M., Michalczyk, K., Cichosz, M., Młynarski, W. Chemotherapy Delays In Children With Acute Lymphoblastic Leukemia Might Influence The Outcome Of Treatment. Acta Haematol. Pol. 2022;53(2): 41-148. Available from https://doi.org/10.5603/AHP.a2022.0007
  15. Zhang L, Liu J, Qin X, Liu W. Platelet–acute leukemia interactions. Clinica Chimica Acta. 2022;536:29-38. Available from https://doi.org/10.1016/j.cca.2022.09.015
  16. Wali, R., Anjum, S., Amjad, A., Shaheen, N. and Khan, S.J. Frequency of Infectious Mortality at the End of Induction Chemotherapy in Acute Lymphoblastic Leukemia and Lymphoma Patients: Findings From a Tertiary Care Cancer Center. Cureus. 2021;13(2):1-6. Available from https://doi.org/10.7759/cureus.13208

How to Cite

Wicaksono, S., Andarsini, M. R., Ugrasena, I. D. G., Cahyadi, A., Larasati, M. C. S., & Nugroho, S. (2023). Hematologic Recovery in Pediatric Patients with Acute Lymphoblastic Leukemia After Induction Chemotherapy. Bali Medical Journal, 13(1), 143–147. https://doi.org/10.15562/bmj.v13i1.4910

HTML
8

Total
6

Share

Search Panel

Sony Wicaksono
Google Scholar
Pubmed
BMJ Journal


Mia Ratwita Andarsini
Google Scholar
Pubmed
BMJ Journal


I Dewa Gede Ugrasena
Google Scholar
Pubmed
BMJ Journal


Andi Cahyadi
Google Scholar
Pubmed
BMJ Journal


Maria Christina Shanty Larasati
Google Scholar
Pubmed
BMJ Journal


Susanto Nugroho
Google Scholar
Pubmed
BMJ Journal